Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001660410-16-000002
Filing Date
2016-11-23
Accepted
2016-11-23 15:45:34
Documents
1
Effectiveness Date
2016-11-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7421
  Complete submission text file 0001660410-16-000002.txt   8509
Mailing Address 99 HAYDEN AVENUE BUILDING D, SUITE 100 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING D, SUITE 100 LEXINGTON MA 02421 858 999 4413
Ribon Therapeutics, Inc. (Filer) CIK: 0001660410 (see all company filings)

EIN.: 473651475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-253249 | Film No.: 162016510